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Abstract
Background: Inuit women are highly exposed through their traditional seafood based diet to
organochlorine compounds, some of them displaying endocrine disrupting properties. We
hypothesized that this exposure might be related to bone characteristics that are altered in
osteoporosis, because hormone deficiency is a known risk factor for the disease.
Methods: We measured quantitative ultrasound parameters (QUS) at the right calcaneum of 153
peri- and postmenopausal Inuit women (49–64 year old) from Nuuk, Greenland, and investigated
the relation between these parameters and plasma organochlorine concentrations. We used high-
resolution gas chromatography with electron capture detection to analyze plasma samples for 14
polychlorinated biphenyls (PCB) congeners and 11 chlorinated pesticides and metabolites. We
analysed morning urine samples for cadmium, a potential confounder, by atomic absorption
spectrometry. We used a validated questionnaire to document dietary and lifestyle habits as well
as reproductive and medical histories.
Results: Concentrations of PCB 153, a surrogate of exposure to most organochlorines present in
plasma samples, were inversely correlated to QUS parameters in univariate analyses (p < 0.001).
However, PCB 153 concentrations were not associated with QUS values in multivariate analyses
that comprised potential confounding factors such as age, body weight, former oral contraceptive
use and current hormone replacement therapy (HRT) use, which were all significant predictors of
bone stiffness (total R2 = 0.39; p < 0.001).
Conclusion:  Overall we found little evidence that organochlorines exposure is related to
osteoporosis in Greenlandic Inuit women, but the hypothesis that exposure to dioxin-like
compounds might be linked to decreased bone quality and osteoporosis deserves further attention.
Published: 21 December 2006
Environmental Health: A Global Access Science Source 2006, 5:33 doi:10.1186/1476-069X-5-33
Received: 21 September 2006
Accepted: 21 December 2006
This article is available from: http://www.ehjournal.net/content/5/1/33
© 2006 Côté et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Environmental Health: A Global Access Science Source 2006, 5:33 http://www.ehjournal.net/content/5/1/33
Page 2 of 10
(page number not for citation purposes)
Background
Osteoporosis is commonly defined as a decrease in bone
mineral density (BMD) and the microarchitectural deteri-
oration of bone tissue [1]. It is a multifactorial chronic dis-
ease that may progress silently for decades until
characteristic fractures occur late in life. This bone fragility
increases considerably the risk of osteoporotic fractures,
such as those of the distal radius, humerus, spine and hip
that often appear in older women following a minimal
trauma. Hip fractures lead to rehabilitation problems and
greatly decrease the quality of life [2,3].
Risk factors for osteoporosis in women include advanced
age, small body size, cigarette smoking, hormone defi-
ciency, genetics, low physical activity, low intake of cal-
cium and vitamin D, menopausal status, the use of certain
drugs (eg, glucocorticoids) as well as several medical dis-
orders [4,5]. Exposure to environmental chemicals that
are able to disrupt the hormonal equilibrium might repre-
sent another risk factor for this disease [6]. More specifi-
cally, in view of the important role of estrogen deficiency
in the osteoporotic process [7], compounds that can inter-
act with estrogen receptors or alter estrogen metabolism
could be involved in the pathogenesis. Certain environ-
mental chemicals that are part of the organochlorine
(OC) family, a group of persistent and bioaccumulative
chemicals that have been used extensively in agriculture
and various industrial applications between 1930 and
1980, can modulate the estrogen signalling pathway,
namely polychlorinated biphenyls [8], β-hexachlorocy-
clohexane [9] and 2,3,7,8-tetrachlorodibenzo-p-dioxin
and structurally-related compounds [10-12]. Results from
two recent studies suggest a possible relation between
osteoporosis and exposure to OCs [13,14].
High concentrations of OCs have been found in plasma
samples from adult Greenlanders compared to those
reported for southern Canada and European populations
[15,16]. OCs are transported from industrialized areas of
the planet to the Arctic by ocean and air currents [17-19],
where they condensate and are biomagnified in predator
species located at the top of the marine food chain, such
as predator fish and sea mammals [17,18,20]. The tradi-
tional Inuit diet comprises large amounts of sea mammal
and is the major source of OC exposure in this population
[17,18,20-22]. In view of the unusually high exposure to
OCs in Greenland, we set out to examine the associations
between OCs plasma concentrations and ultrasound bone
measurements among peri- and postmenopausal Green-
landic Inuit women. QUS parameters have been shown to
be strongly associated with future fracture risk [23,24]. We
also measured the concentration of cadmium in urine
because low-level cadmium exposure has been linked to
osteoporosis [25,26] and therefore it represents a possible
confounding factor.
Methods
Population
This descriptive cross sectional study was conducted dur-
ing September 2000 in Nuuk, Greenland, home to a total
population of approximately 14,000 inhabitants. To be
eligible, women had to be born in Greenland and aged
between 49 and 64 years. A random sample of 200
women was taken from the Greenland statistics list com-
prising 547 eligible women. Of the 200 women, 7 had
died, 11 had moved to another town and 15 were out of
town at the time of the study (not for medical reasons).
Thus, 167 women were invited to participate to the study;
eight declined, for a participation rate of 95%. Six women
were excluded because of illnesses (human immunodefi-
ciency virus, mental disorder and flu) and therefore 153
women completed the study.
Measurements and analyses
After obtaining information on the study and signing an
informed consent, participants completed a detailed and
validated Danish questionnaire with the assistance of a
qualified interviewer during a face-to-face interview. The
questionnaire was adapted from the Mediterranean Oste-
oporosis Study Questionnaire (MEDOS) [27] and
allowed to document the following risk factors for oste-
oporosis: smoking habits, physical activity, daily milk
products and calcium supplement consumption, current
use of HRT and former contraceptive use. Questions were
also asked to document secondary causes of osteoporosis
such as Cushing's disease, renal and liver deficiency,
hyper- and hypothyroidism, bone cancer and rheumatoid
arthritis.
Weight, height and waist, abdominal and hip girth were
measured using standardized techniques. Women were
considered postmenopausal if they had no menses for at
least one year before the recruitment, if they underwent
bilateral oophorectomy more than 6 months ago and if
analysis had revealed a follicle stimulating hormone con-
centration greater than 40 IU/L.
Blood samples (10 ml) were collected in vials containing
EDTA as the anticoagulant, centrifuged (10 min, 3000
rpm) and the plasma poured into glass vials pre-rinsed
with hexane. First morning urine samples were collected
in plastic vials. Plasma and urine samples were stored fro-
zen at -80°C until time of analysis for OCs and cadmium
respectively, at the Centre de Toxicologie (CTQ) of the Insti-
tut National de Santé Publique du Québec (Québec, Can-
ada). This laboratory is accredited by the Canadian
Association for Environmental Analytical Laboratories.
Fourteen PCB congeners [International Union for Pure
and Applied Chemistry (IUPAC) no. 28, 52, 99, 101, 105,
118, 128, 138, 153, 156, 170, 180, 183, 187], p, p'-DDTEnvironmental Health: A Global Access Science Source 2006, 5:33 http://www.ehjournal.net/content/5/1/33
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(dichlorodiphenyltrichloroethane) and its major metabo-
lite p, p'-DDE (p, p'-dichlorodiphenyl-dichloroethylene),
hexachlorobenzene (HCB) and 8 other chlorinated pesti-
cides [α-chlordane, γ-chlordane, aldrin, β-hexachlorocy-
clohexane (β-HCH), mirex, oxychlordane, cis-nonachlor,
and  trans-nonachlor] were analysed by high-resolution
gas chromatography with electron capture detection. A
1:1:3 mixture of ammonium sulfate:ethanol:hexane was
first added to the plasma to extract OCs. The extracts were
then concentrated and purified on two Florosil columns
(60–100 mesh; Fisher Scientific, Nepean, Ontario, Can-
ada). The OCs were measured in the purified extracts with
an HP 5890 high-resolution gas chromatograph equipped
with dual-capillary columns (HP Ultra I and Ultra II) and
dual Ni-63 electron capture detectors (Hewlett-Packard,
Palo Alto, CA, USA). The limit of detection was based on
3 times the average standard deviation of noise and was
0.08 μg/L for p, p'-DDE, p, p'-DDT and β-HCH, and 0.04
μg/L for all other compounds. The average percent recov-
eries were greater than 95%. Coefficients of variations
(CVs) based on repeated analyses of a standard reference
material (SRM 1589; N = 15) ranged from 3.9% to 18.5%,
except for PCB 105 and p, p'-DDT, for which CVs were
31.6% and 26.2%, respectively.
Plasma OC concentrations were expressed on a lipid
basis. We calculated the total plasma lipid concentration
from the concentrations of cholesterol esters, free choles-
terol, triglycerides and phospholipids [28], which were
measured using standard enzymatic procedures.
Urine samples were analysed for cadmium by graphite
furnace atomic absorption spectrometry and concentra-
tions were corrected for urinary creatinine content to take
into account differences in urinary output between partic-
ipants. Duplicates were run every 10 samples. The CV of
the method based on repeated analyses of a standard ref-
erence material from CTQ interlaboratory comparison
program (N = 34) was 2.0%, and the limit of detection
was 0.2 μg/L.
Bone measurements
QUS bone measurements were performed at the right cal-
caneum using the Achilles™ ultrasound bone densitome-
ter (Lunar Corporation, Madison, WI, USA). This
technique is fast (approximately 3 minutes), simple, non
invasive, safe (radiation-free), inexpensive and portable.
The heel is immersed in water and an ultrasonic pulse
propagates through the bone. Three QUS parameters were
measured: 1) broadband ultrasound attenuation (BUA,
dB/MHz), which reflects bone density as well as its archi-
tecture; 2) speed of sound (SOS, m/sec), which reflects
bone density and elasticity; and 3) bone stiffness index
(SI, %), which reflects the rigidity of the bone structure. SI
was computed from BUA and SOS measurements using
the manufacturer's equation and expressed as a percent-
age of young adults' average peak SI. The densitometer
was calibrated daily using the acoustic phantom provided
by the manufacturer and showed no drift. In vivo precision
was evaluated by repeated measurements conducted
among 15 subjects: CVs were 0.8% for BUA, 0.2% for SOS
and 1.1% for SI.
Statistical analysis
Because distribution of values for organochlorine concen-
trations in plasma lipids and urinary cadmium concentra-
tions were skewed right, they were log-transformed and
the geometric mean was used as the measure of central
tendency. A concentration equal to half of the detection
limit was given for samples with levels below the detec-
tion limit. Means of bone measurements were compared
for dichotomous risk factors using Student's t tests. We
used Pearson's correlation coefficients to assess correla-
tions between QUS measurements and continuous risk
factors. PCB 153 was used as a surrogate of the organo-
chlorine mixture present in the traditional diet because
concentrations of this congener in plasma were strongly
correlated to those of most other OCs. Nevertheless, since
β-HCH, p, p'-DDE and HCB were not as strongly corre-
lated to PCB 153 (Pearson's r = 0.75–0.78), statistical
analyses were also performed with these variables. In
order to verify the association between bone measure-
ments and concentrations of OCs, multivariate regression
analyses were performed. We evaluated the confounding
effect of osteoporosis risk factors on the relation between
OCs and QUS parameters and retained only factors asso-
ciated with bone measurements (p ≤ 0.10) in the regres-
sion models. Statistical significance was set at α = 0.05.
Multiple linear regression assumptions regarding the
homogeneity of variance and the normality of residues
were met when log-transformed OC concentrations were
entered in the models. Statistical analyses were performed
using SAS Statistical program version 8.0 (SAS Institute
Inc., Cary, NC, USA).
Results
Our study population consisted of 153 Inuit women,
mostly postmenopausal whose age ranged between 49
and 64 years (Table 1). Approximately half of the women
had a body mass index (BMI) exceeding 27 kg/m2. Most
were sedentary, smoked cigarettes, and were not taking
calcium supplement or HRT at the time of the study. A
majority of women also never used contraceptives. Mean
(geometric) urinary cadmium concentration was 1.4 μg/g
creatinine (95%-confidence interval = 1.3–1.6), with val-
ues ranging from 0.2 to 7.6 μg/g creatinine (N = 141).
Concentrations of the 25 OCs measured in plasma sam-
ples from the 153 participating women are shown in
Table 2. Data are provided only for compounds for whichEnvironmental Health: A Global Access Science Source 2006, 5:33 http://www.ehjournal.net/content/5/1/33
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70% of the samples contained concentrations above the
detection limit of the analytical method. The geometric
mean concentration of the sum of 14 PCB congeners
(ΣPCBs) was 2051 μg/kg. The most prominent congeners
were PCB 153, PCB 138 and PCB 180. These three di-
ortho substituted congeners represented 66% of ΣPCBs.
Three mono-ortho substituted congeners – PCB 105, PCB
118 and PCB 156 – were detected in almost all samples
and represented 11% of ΣPCBs. p, p'-DDE, the main DDT
metabolite, was the chlorinated pesticide with the highest
plasma concentration (mean concentration above 1000
μg/Kg), followed by trans-nonachlor, hexachlorobenzene,
and oxychlordane, with mean concentrations between
200 and 400 μg/Kg.
Frequency distributions for QUS parameters measured at
the right calcaneum of the 153 women are shown in Fig-
ure 1. Mean values for BUA, SOS, and SI were respectively
108 dB/MHz (Standard deviation (SD) = 11; range = 68–
140), 1523 m/sec, (SD = 26; range = 1463–1595) and
79% (SD = 14; range = 47–117).
We first tested relations between QUS parameters and
selected dichotomous risk factors for osteoporosis and
noted that postmenopausal women, women who were
not currently using HRT and those who never used contra-
ceptives had significantly lower values of all three QUS
parameters compared to their respective counterparts
(Table 3). The level of physical activity was marginally
linked to BUA, SOS and SI values. Smoking and taking
calcium supplements only influenced BUA values, while
the consumption of dairy products had no statistically-
significant influence on QUS measurements. Correlation
analyses revealed that age was negatively correlated to all
three QUS parameters (Pearson's r ranging from -0.31 to -
0.42; p < 0.001). All anthropometric measurements were
positively correlated to QUS measurements but the
strongest correlations were observed for weight (r = 0.33 –
0.50; p < 0.001) and height (r = 0.41 – 0.46; p < 0.001).
Urinary cadmium concentrations were negatively corre-
lated to QUS parameters (r varying from -0.23 to -0.29; p
< 0.005).
Correlations coefficients between QUS parameters and
concentrations of selected organochlorines in plasma are
listed in Table 4. Concentrations of PCB 153 (log-trans-
formed) were negatively correlated to BUA, SOS and SI
measurements (p  < 0.001). We also tested correlations
between QUS parameters and other OCs that were not
strongly correlated to PCB 153 levels. Hexachlorobenzene
concentrations were correlated with the three QUS param-
eters, but not those of p, p'-DDE and β-HCH.
Results of multiple linear regression analyses are pre-
sented in Table 5. PCB 153 was not associated with QUS
parameters in models that included potential confound-
ing factors, although associations were nearly significant
in SOS and BUA models (p = 0.072). The significant inde-
pendent predictors of QUS measurements were age,
weight, current HRT use and former oral contraceptives
use. These variables accounted for 38%, 34% and 39% of
the variance in BUA, SOS and SI values respectively (p <
0.001). Urinary Cd concentration was not retained in the
final regression models as it was not associated with any
of the bone measurements (p > 0.7). HCB concentrations
were also not associated with QUS parameters in multi-
variate analyses (data not shown). Additional exploratory
analyses were conducted with concentrations of mono-
Table 1: Characteristics of the 153 peri- and postmenopausal Inuit women
Variables Mean ± SD  Min Max Variables Categories %
Age (years) 55.3 ± 4.4 49.0 64.0 Smoking habits Smoker
Former smoker
Never smoker
74.5
11.8
13.7
Weight (kg) 68.0 ± 15.2 36.0 102.0 Physical activity Sedentary
Active*
73.9
26.1
Height (cm) 156.2 ± 6.6 142.0 171.0 Dairy products (Portions per day) 0 to 2
3 and more
71.3
28.7
Body mass index (kg/m2) 27.9 ± 6.1 14.4 43.4 Calcium supplement use Yes
No
8.5
91.5
Waist circumference (cm) 93.4 ± 14.4 64.0 131.0 Menopausal (n = 141) Yes
No
87.9
12.1
Abdominal circumference (cm) 96.3 ± 14.2 67.0 129.0 Current HRT use Yes
No
8.5
94.8
Hip circumference (cm) 103.3 ± 10.3 82.0 130.0 Former contraceptive use Yes
No
40.5
59.5
*Active: at least one period of physical activity (20–30 min duration) per week over the last three months; sedentary: less than one period of 
physical activity per week.Environmental Health: A Global Access Science Source 2006, 5:33 http://www.ehjournal.net/content/5/1/33
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ortho substituted PCB congeners, even though concentra-
tions of these congeners were highly correlated to those of
PCB 153 (Pearson's r ≥ 0.90). In similar models (data not
shown), statistically significant associations were noted
between PCB 156 concentrations and BUA (β = -8.12;
standard error (SE) = 3.65; p = 0.028), SOS (β = -22.68; SE
= 9.07; p = 0.014) and SI values (β = -11.95; SE = 4.53; p =
0.009). Concentrations of PCB 105 and PCB 118 were not
associated with QUS parameters in multivariate models.
Discussion
This cross-sectional study was designed to investigate the
association between exposure to OCs and osteoporosis-
related ultrasound bone measurements in peri- and post-
menopausal Inuit women from Greenland. Exposure of
the Greenlandic Inuit population to OCs is high com-
pared to North American and European populations [15]
and we hypothesized that exposure to these compounds
might favor the osteoporotic process. We found no statis-
tically-significant association between QUS parameters
and concentrations of PCB 153, a surrogate for exposure
to the majority of OCs present in plasma samples of par-
ticipants.
Some studies have investigated the relation between
biomarkers of OC exposure and the risk of fractures in
women. Alveblom et al. [13] compared fracture risks
between fishermen and their wives from the Swedish east
coast on the Baltic Sea (exposed to OCs through fatty fish
consumption) and west coasts (unexposed). The authors
retrieved information on vital status and hospitalization
of 17,823 persons from 1987 to 1996, among which 671
had been hospitalized due to osteoporotic fractures. Pois-
son regression models taking age and calendar year into
account revealed a significantly increased incidence rate
ratio (IRR: 2.29, 95% confidence intervals (CI): 1.23–
4.28) for vertebral fractures among east-coast women. The
authors could not exclude that confounding from differ-
ences in smoking habits between the populations might
explain part of the observed effects. Wallin et al [29] con-
ducted a questionnaire study to further assess the impact
of consuming OC-contaminated fish on the self-reported
fracture incidence in fishermen and their wives from
Swedish east and west coasts. Hip, vertebral, and wrist
fractures were classified as osteoporotic. No differences in
fracture incidence were observed between the east-coast
(exposed) and west-coast (unexposed) cohorts. East-coast
Table 2: Plasma organochlorine concentrations (μg/kg lipids) in the 153 peri- and postmenopausal Inuit women
Variables % detected Geometric mean (95% CI) Min Max
PCBs (IUPAC No)
28 83 7.7 (6.8–8.7) ND* 111.1
52 76 7.3 (6.4–8.4) ND 80.0
99 100 88.0 (80.1–96.6) 9.3 294.7
101 84 8.9 (7.9–10.0) ND 36.6
105 98 22.5 (20.2–25.1) ND 77.7
118 100 121.9 (111.9–132.8) 19.7 371.8
128 23
138 100 418.2 (384.4–454.9) 70.6 1385
153 100 578.6 (530.2–631.3) 93.8 1993
156 100 77.2 (70.9–83.9) 11.4 295.9
170 100 132.5 (121.4–144.6) 20.7 606.4
180 100 350.6 (319.8–384.4) 57.9 1709
183 100 41.7 (38.3–45.4) 7.4 160.0
187 100 164.3 (150.7–179.0) 24.2 660.3
ΣPCBs 100 2051 (1886–2229) 341 7384
Chlorinated pesticides
Aldrin 3
β-HCH 100 49.4 (46.3–52.6) 16.2 134.6
γ-Chlordane 25
cis-Nonachlor 100 87.2 (79.3–96.0) 9.5 287.5
p, p'-DDE 100 1192 (1083–1313) 94.2 6464
p, p'-DDT 95 33.5 (29.9–37.6) ND 145.6
HCB 100 289.0 (264.3–316.0) 56.9 1458
Mirex 100 39.6 (34.9–45.0) ND 242.4
Oxychlordane 100 214.6 (192.6–239.0) 15.9 1268
trans-Nonachlor 100 388.7 (351.8–429.5) 40.7 1903
*ND; not detectedEnvironmental Health: A Global Access Science Source 2006, 5:33 http://www.ehjournal.net/content/5/1/33
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Frequency distributions of right calcaneal QUS bone measurements in 153 peri- and postmenopausal Inuit women Figure 1
Frequency distributions of right calcaneal QUS bone measurements in 153 peri- and postmenopausal Inuit women.
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wives with more than one meal of fatty fish from the Bal-
tic Sea per month had, however, an increased fracture inci-
dence as compared with that of the east-coast wives who
ate, at most, one such a meal per month (age-adjusted IRR
= 1.68, 95% CI = 1.00–2.84). In both of these studies, OC
exposure was indirectly assessed through fish consump-
tion, which might have introduced misclassification of
exposure.
Few studies investigated relations between OC exposure
and bone mineral density measurements. No association
was found between plasma p, p'-DDE concentrations and
BMD measured at the lumbar spine and radius in 103
peri- and postmenopausal American women (mean age =
54.5 years) who had participated in the Mount Sinai Med-
ical Center Longitudinal Normative Bone Density Study
from 1984 to 1987 [30]. Beard et al. [14] examined the
relationship between serum p, p'-DDE concentrations and
bone mineral density in 68 Australian sedentary women
aged 45 to 64 years old. The authors observed that p, p'-
DDE levels (mean serum concentration = 3.9 ppb) were
negatively correlated to BMD (r = -0.27, p = 0.03). The
strongest multivariate model explained 21% of bone min-
eral density variation (p  = 0.002) and comprised log-
transformed p, p'-DDE concentrations (p = 0.018), age (p
= 0.002), and years of HRT use (p = 0.10) as predictor var-
iables. Finally, Wallin et al. [31] recruited 184 wives of
fishermen from the east coast of Sweden (median age 62
years) to participate in an examination of their forearm
BMD, using dual energy x-ray absorptiometry (DXA). Uni-
Table 3: Univariate analyses of relations between quantitative ultrasound bone measurements and risk factors for osteoporosis (n = 
153)
BUA (dB/MHz) SOS (m/sec) Stiffness index (%)
Mean ± SD p-value* Mean ± SD p-value* Mean ± SD p-value*
Smoking habits
Smoker 107.2 ± 11.5 0.025 1521.9 ± 27.3 0.409 77.5 ± 14.5 0.099
Former and never smoker 110.9 ± 7.7 1525.9 ± 22.4 81.1 ± 10.5
Physical activity
Sedentary 107.2 ± 10.9 0.075 1520.6 ± 25.2 0.064 77.2 ± 13.4 0.048
Active 110.8 ± 10.0 1529.5 ± 28.0 82.1 ± 13.7
Dairy products
0 to 2/day 108.4 ± 10.8 0.668 1523.3 ± 26.6 0.767 78.7 ± 13.7 0.713
≥3/day 107.6 ± 10.8 1521.9 ± 25.2 77.8 ± 13.5
Calcium supplement
Yes 114.2 ± 5.6 0.001 1527.8 ± 22.0 0.485 83.9 ± 9.2 0.130
No 107.6 ± 11.0 1522.5 ± 26.5 78.0 ± 13.9
Menopause
Yes 106.7 ± 9.9 0.024 1518.9 ± 24.7 0.001 76.3 ± 12.6 0.003
No 112.8 ± 13.5 1540.4 ± 28.9 86.5 ± 16.3
Current HRT use
Yes 117.1 ± 9.7 0.002 1546.9 ± 20.0 < 0.001 91.3 ± 10.8 < 0.001
No 107.3 ± 10.5 1520.7 ± 25.6 77.3 ± 13.2
Former contraceptive use
Yes 112.1 ± 9.8 < 0.001 1534.3 ± 25.1 < 0.001 84.3 ± 12.7 < 0.001
No 105.4 ± 10.6 1515.1 ± 24.0 74.5 ± 12.8
*Student t Test
Table 4: Pearson's correlation coefficients (r) between quantitative ultrasound bone measurements and plasma organochlorines 
concentrations (n = 153)
BUA (dB/MHz) SOS (m/sec) Stiffness index (%)
rp -value rp -value rp -value
PCB 153 (log) -0.29 < 0.001 -0.32 < 0.001 -0.33 < 0.001
β-HCH (log) -0.02 0.784 -0.09 0.252 -0.06 0.427
p, p'-DDE (log) -0.06 0.479 -0.10 0.236 -0.08 0.306
HCB (log) -0.17 0.035 -0.26 0.001 -0.23 0.004Environmental Health: A Global Access Science Source 2006, 5:33 http://www.ehjournal.net/content/5/1/33
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variate analyses showed significant negative associations
between BMD and PCB 153 or p, p'-DDE concentrations,
but after adjustment for age and body mass index, these
associations did not remain, similarly to what was
observed in the present study.
Additional exploratory analyses in our study revealed sig-
nificant associations between QUS bone measurements
and PCB 156 concentrations, a congener with dioxin-like
properties. Animal studies have shown that dioxin-like
OCs may impair normal bone metabolism and result in
increased bone fragility [32-34]. PCB 126, a non-ortho
coplanar PCB congener, impaired the mineralization
process of tibiae in rats [33] and also reduced the collagen
content and serum osteocalcin concentrations, resulting
in impaired maximum torque and stiffness of the rat
humerus [34]. Although biologically plausible, the associ-
ation noted between PCB 156 and QUS parameters may
be due to chance and needs to be replicated in another
study in which all dioxin-like OCs would be measured
and taken into consideration in statistical analyses.
Data on bone measurements and osteoporosis risk factors
obtained in the 153 Inuit women can be compared to
those gathered from 2972 southern Quebec women of the
same age group (mean = 55.8 years, ranging form 49–64
years old) who were recruited during the same period by
our research group (unpublished data). The same ques-
tionnaires and ultrasound apparatus were used for data
collection in both settings. The mean ± SD for BUA in
southern Quebec women was 112 ± 9 dB/MHz, 1545 ± 29
m/sec for SOS and 87 ± 13% for SI. Mean values for BUA,
SOS and SI in Inuit women from Greenland are respec-
tively 4%, 1.4% and 9.5% lower that those measured in
southern Quebec women. A larger proportion of Inuit
women smoked (74.5% vs 14.5%) and was sedentary
(73.9% vs 24.7%), while a smaller proportion of Inuit
women was taking calcium supplements (8.5% vs 46.7%)
and HRT (8.5% vs 51.9%) compared to southern Quebec
women. Furthermore, mean weight (68.0 vs 66.4 kg) and
BMI (27.9 vs 26.5 kg/m2) were slightly higher in Green-
landic Inuit women than in southern Quebec women.
These differences in osteoporosis risk factors might
explain the lower values for QUS measurements obtained
in Greenlandic Inuit women compared to women from
southern Quebec.
Other studies conducted in Alaska have shown that Inuit
women are at risk for osteoporosis. A study conducted in
the 70's using direct photon absorptiometry revealed that
Alaskan Inuit women had an earlier onset and greater
intensity of bone loss beginning in the forties, around
menopause, compared to Caucasian women in the US.
Alaskan Inuit women lost on average 5% more bone mass
per decade than Caucasian American women [35,36].
Martin et al. [37] reported that the bone mineral content
of Inuit women decreased by 50% between the third and
sixth decades. More recently, Filner et al. [38] evaluated
the prevalence of risk factors for osteoporosis in women
from 13 geographic areas in Alaska and noted that low
bone density (defined as a T-score of -1.0 or less) meas-
ured at the calcaneum by ultrasonography was more prev-
alent in Native than non-Native women (45.3% in Native
vs 22.1% in non-Native, p < 0.001). These authors con-
cluded that increasing calcium intake and decreasing the
prevalence of smoking would likely reduce the prevalence
of osteoporosis in Native women.
A limitation of our study is its cross-sectional design,
which can lead to an underestimation of the true associa-
tion because some subjects might not have been available
at the time of ascertainment. Moreover, the exposure is
measured at the same time as the health condition of the
subject, which makes it difficult to correctly establish a
causal relation. Also, our assessment of the physical activ-
ity was based on a single question, which documented
how many times per week during the last three months
had the woman practiced a physical activity for at least 20
to 30 minutes. This question which was validated in a
group of workers from southern Canada [39] might have
introduced some information bias. Finally, our study
relied on QUS measurements at the right calcaneum to
Table 5: Multiple regression models for predicting quantitative ultrasound bone measurements (n = 153)
Variables BUA (dB/MHz) SOS (m/sec) Stiffness index
β (SE)* p-value β (SE)* p-value β (SE)* p-value
R2 0.38 <0.001 0.34 <0.001 0.39 <0.001
PCB 153 (log)* -4.59 (3.20) 0.153 -14.41 (7.95) 0.072 -7.19 (3.98) 0.072
Age (years) -0.33 (0.18) 0.071 -1.54 (0.45) 0.001 -0.65 (0.22) 0.004
Weight (kg) 0.31 (0.05) <0.001 0.40 (0.12) 0.001 0.31 (0.06) <0.001
Current HRT use 6.26 (2.60) 0.017 16.31 (6.46) 0.013 8.93 (3.23) 0.006
Former contraceptive use 3.38 (1.56) 0.031 9.78 (3.87) 0.012 4.93 (1.94) 0.012
*Regression coefficients (standard error)Environmental Health: A Global Access Science Source 2006, 5:33 http://www.ehjournal.net/content/5/1/33
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assess bone properties instead of the gold-standard verte-
bral BMD measurements. Several studies have however
shown that QUS measurements are good predictors of the
bone density and quality that are related to the risk of
osteoporosis [24,40-43] and to the risk of fracture in early
postmenopausal women [41,43].
Conclusion
In summary, we observed that plasma OC concentrations
were not associated with QUS parameters in multivariate
models adjusted for age, body size and hormone intake.
Exploratory analyses indicated that PCB 156, a congener
with limited dioxin-like activity, might be related to bone
measurements in this population, but this hypothesis
clearly needs to be tested in another setting. We are cur-
rently studying the relation between OC exposure and
QUS measurements in Inuit women from Nunavik (Arctic
Quebec, Canada). In this study, the concentration of all
dioxin-like compounds in plasma of participants will be
measured by the dioxin-receptor chemical-activated luci-
ferase expression (DR-CALUX) assay. Women will be fol-
lowed prospectively in order to accurately define the onset
and the rate of bone loss. In the meantime, actions should
be taken to reduce the prevalence of smoking in Greenlan-
dic Inuit women, which is a known risk factor of oste-
oporosis. In addition, dietary supplementation with
calcium and vitamin D [44] might also be warranted in
this population.
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